Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency [4]

  1. Resino, S.
  2. Bellón, J.M.
  3. Muñoz-Fernández, M.A.
  4. Ramos, J.T.
  5. Carreño, P.
  6. Ruiz, J.
  7. Clemente, J.
  8. Gurbindo, M.D.
  9. Navarro, M.L.
  10. Alvaro-Meca, A.
  11. Muñoz-Fernández, M.A.
  12. de Jose, I.M.I.
  13. Martín-Fontelos, P.
  14. Mellado, M.J.
  15. Villota, J.
  16. León Leal, J.A.
  17. Fortuny, C.
  18. Tello, L.M.
  19. Bertrán, J.M.
  20. García, L.
  21. Mur, A.
  22. González-Montero, R.
  23. Pocheville, I.
  24. Gutierrez, C.
  25. Ciria, L.
  26. Dueñnas, J.
  27. Orti, A.
  28. Otero, M.C.
  29. Asensi, F.
  30. Garcia, M.
  31. Cabrero, E.
  32. Usán, L.
  33. Show all authors +
Journal:
Journal of Antimicrobial Chemotherapy

ISSN: 1460-2091 0305-7453

Year of publication: 2006

Volume: 57

Issue: 3

Pages: 579-582

Type: Letter

DOI: 10.1093/JAC/DKI469 GOOGLE SCHOLAR lock_openOpen access editor